These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38099363)

  • 1. A study to determine the effect of hydroxychloroquine (HCQ) on central corneal thickness (CCT) in patients with rheumatoid arthritis (RA).
    Jaichander RC; Thomas RK; Shobha V
    Indian J Ophthalmol; 2024 Feb; 72(2):270-274. PubMed ID: 38099363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
    Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M
    Glob J Health Sci; 2015 Jun; 8(3):59-64. PubMed ID: 26493438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal thickness and endothelial changes in long-term hydroxychloroquine use.
    Oğurel T; Özer MA; Akbulut Y; Gökçınar NB; Onaran Z; Üreten K
    Cutan Ocul Toxicol; 2019 Sep; 38(3):286-289. PubMed ID: 31010339
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
    Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
    Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
    Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE
    Arthritis Rheum; 2002 Jun; 46(6):1460-9. PubMed ID: 12115175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroidal Thickness Changes in Rheumatoid Arthritis and the Effects of Short-term Hydroxychloroquine Treatment.
    Karti O; Ayhan Z; Zengin MO; Kaya M; Kusbeci T
    Ocul Immunol Inflamm; 2018; 26(5):770-775. PubMed ID: 28282737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis.
    Zhang Z; Ma X; Wang YH; Shi X; Wei JC
    Sci Rep; 2023 Apr; 13(1):5576. PubMed ID: 37019978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
    Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
    Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
    Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Corneal and Retinal Toxicity in Rheumatoid Arthritis Patients Treated with Hydroxychloroquine.
    Qian Y; Zhou D; Zhu D; Shi T; Zou J; Ma X
    Ophthalmic Res; 2022; 65(6):659-667. PubMed ID: 35705064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
    Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
    Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
    Front Immunol; 2021; 12():631869. PubMed ID: 33868251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
    Faselis C; Zeng-Treitler Q; Cheng Y; Kerr GS; Nashel DJ; Liappis AP; Weintrob AC; Karasik PE; Arundel C; Boehm D; Heimall MS; Connell LB; Taub DD; Shao Y; Redd DF; Sheriff HM; Zhang S; Fletcher RD; Fonarow GC; Moore HJ; Ahmed A
    Arthritis Rheumatol; 2021 Sep; 73(9):1589-1600. PubMed ID: 33973403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
    Ahn SJ; Ryu SJ; Joung JY; Lee BR
    Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Arthritis Care Res (Hoboken); 2020 Jan; 72(1):36-40. PubMed ID: 30629341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study.
    Khoubnasabjafari M; Jouyban A; Malek Mahdavi A; Namvar L; Esalatmanesh K; Hajialilo M; Dastgiri S; Soroush M; Safiri S; Khabbazi A
    Postgrad Med J; 2022 Mar; 98(e2):e92-e93. PubMed ID: 35232849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.